New River Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 700 Wenonah Ave, Pearisburg, VA 24134 Phone: 540-921-4116 Fax: 540-921-4118 |
Dr. Bradley Mart Lane, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 700 Wenonah Ave, Pearisburg, VA 24134 Phone: 540-921-4116 |
Clarity Eye Care, Plc Optometrist Medicare: Medicare Enrolled Practice Location: 122 Tazewell St, Pearisburg, VA 24134 Phone: 540-921-3921 Fax: 540-921-1328 |
Dr. Daniel Layne Bowling, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 122 Tazewell St, Pearisburg, VA 24134 Phone: 540-921-3921 Fax: 540-921-1328 |
Mr. Nickolas Wilson Clark, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 122 Tazewell St, Pearisburg, VA 24134 Phone: 540-921-3921 Fax: 540-921-1328 |
New River Eye Care Family Optometry Pc Optometrist Medicare: Medicare Enrolled Practice Location: 700 Wenonah Ave, Pearisburg, VA 24134 Phone: 540-921-4116 Fax: 540-921-4118 |
Helen Jacqueline Clark, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 122 Tazewell St, Pearisburg, VA 24134 Phone: 540-921-3921 Fax: 540-921-1328 |
News Archive
The Mayo Practice Transformation Network is one of 39 health care collaborative networks selected to participate in the Transforming Clinical Practice Initiative, announced today by U.S. Department of Health and Human Services Secretary Sylvia M. Burwell. Mayo Clinic will receive up to $9.7 million to provide technical assistance support to help equip clinicians in the Mayo Practice Transformation Network with tools, information and network support needed to improve quality of care, increase patients' access to information and spend health care dollars more wisely.
The Global Health Innovative Technology Fund, which in the last two years has funded almost $32 million for innovative tools to tackle global infectious diseases, today announced additional investments of nearly $11 million that bring its portfolio to approximately $43 million.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.
One change to field triage guidelines for emergency medical services responding to older adults with head trauma could make a "clinically important improvement over usual care," according to a study and accompanying editorial published earlier this month in Annals of Emergency Medicine ("Out-of-Hospital Triage of Older Adults With Head Injury: A Retrospective Study of the Effect of Adding 'Anticoagulation or Antiplatelet Medication Use' as a Criterion" and "Can an Out-of-Hospital Medication History Save Lives for Injured Older Adults?").
› Verified 7 days ago